Evidence map›Paper›PMID 42056381›Full record

ArticleBritish journal of cancer2026

Regional HNSCC metabolomics reveals widespread changes to one-carbon metabolism and S-adenosylmethionine metabolism across tumour core, tumour edge and adjacent non-tumour tissues.

Andrew D Southam, James A Higginson, Gavin R Lloyd, Matthew J Smith, Lauren E Cruchley-Fuge, Rachel Spruce, Ossama Edbali, Ralf J M Weber, Hisham Mehanna, Nikolaos Batis

Abstract read
In one paragraph

Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrew D SouthamPhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK. a.d.southam@bham.ac.uk.ORCID http://orcid.org/0000-0003-3030-7663
James A HigginsonInstitute of Head and Neck Studies and Education (InHANSE), Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-6913-1557
Gavin R LloydPhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK.ORCID http://orcid.org/0000-0001-7989-6695
Matthew J SmithPhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK.ORCID http://orcid.org/0000-0002-7357-2670
Lauren E Cruchley-FugePhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK.ORCID https://orcid.org/0009-0002-1307-2102
Rachel SpruceInstitute of Head and Neck Studies and Education (InHANSE), Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Ossama EdbaliPhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK.ORCID http://orcid.org/0000-0003-0132-8668
Ralf J M WeberPhenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, UK.ORCID http://orcid.org/0000-0002-8796-4771
Hisham MehannaInstitute of Head and Neck Studies and Education (InHANSE), Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-5544-6224
Nikolaos BatisInstitute of Head and Neck Studies and Education (InHANSE), Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. n.batis@bham.ac.uk.ORCID https://orcid.org/0000-0002-2305-7427

Funding

Cancer Research UK (CRUK) Birmingham Centre Development FundDH | National Institute for Health Research (NIHR) NIHR300975RCUK | Medical Research Council (MRC) MR/S010483/1RCUK | MRC | Medical Research Foundation MR/ M009157/1RCUK | MRC | Medical Research Foundation MR/S010483/1Wellcome TrustWellcome Trust (Wellcome) ISSF (University of Birmingham)
6 · The paper itself

Abstract

backgroundCancer, including head and neck squamous cell carcinoma (HNSCC), induces changes to metabolism that drive the disease. Regional metabolomics allows understanding of metabolic variation across the tumour, including in the tumour core, where hypoxia is likely more pronounced.

methodsUltra-high performance liquid chromatography-mass spectrometry metabolomics was applied to regionally distinct patient tissue samples: tumour edge, tumour core and adjacent non-tumour. Statistical, correlation and pathway enrichment analyses were performed.

resultsMarkers of hypoxia or pseudohypoxia-lactate, succinate, fumarate, and the lactate:pyruvate ratio-were elevated in both core and edge tumour regions relative to adjacent tissue, with a trend toward stronger changes in the core. One-carbon metabolites were altered in HNSCC, including tumour-associated increases of S-adenosylmethionine (SAM) and SAM metabolites (S-adenosylhomocysteine, polyamines, methylated nucleosides, dimethylarginine, trimethylysine and 1-methylnicotinamide). Histidine, tryptophan, choline and folate appear metabolically connected to one-carbon metabolism in HNSCC: histidine, L-kynurenine (tryptophan metabolite), some purine metabolites (including deoxyguanosine, deoxyinosine) and choline were elevated in tumour tissue; while histidine/SAM, L-kynurenine/deoxyguanosine, L-kynurenine/deoxyinosine and folate/methionine were correlated in tumour tissue only.

conclusionTumour edge and core exhibited one-carbon metabolic changes relative to non-tumour, with the magnitude of change generally greater in the core reflecting location dependent variation of SAM metabolism in HNSCC.

Indexed as

CarbonCarcinoma, Squamous CellHead and Neck NeoplasmsMetabolomicsS-AdenosylmethionineChromatography, High Pressure LiquidHumansSquamous Cell Carcinoma of Head and NeckCarbonS-Adenosylmethionine

Identifiers

PMID42056381
PMCPMC13372809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.